U.S. flag

An official website of the United States government

Format
Items per page
Sort by
Choose Destination

Search results

Items: 1 to 100 of 3777

VariationLocationGene(s)Protein changeCondition(s)Clinical significance
(Last reviewed)
Review status
1.
GRCh37:
Chr3:45921375-50787353
GRCh38:
Chr3:45879883-50749922
ALS2CL, AMIGO3, AMT, APEH, ARIH2, ARIH2OS, ATRIP, ATRIP-TREX1, BSN, BSN-DT, C3orf18, C3orf62, C3orf84, CACNA2D2, CAMKV, CAMP, CCDC12, CCDC51, CCDC71, CCR1, CCR2, CCR3, CCR5, CCR5AS, CCR9, CCRL2, CDC25A, CDHR4, CELSR3, CISH, COL7A1, CRIPTO, CSPG5, CXCR6, CYB561D2, DAG1, DALRD3, DHX30, DOCK3, ELP6, FAM240A, FBXW12, FYCO1, GMPPB, GNAI2, GNAT1, GPX1, HEMK1, HYAL1, HYAL2, HYAL3, IFRD2, IHO1, IMPDH2, INKA1, IP6K1, IP6K2, KIF9, KIF9-AS1, KLHDC8B, KLHL18, LAMB2, LINC02009, LINC02019, LINC02585, LOC101928965, LOC110121200, LOC111591507, LOC112935943, LOC112935944, LOC112935945, LOC112935946, LOC115995510, LOC119086083, LOC121009664, LOC121009665, LOC121009666, LOC121009667, LOC121009668, LOC121009669, LOC121009670, LOC121009671, LOC121725144, LOC122889078, LOC122889079, LOC122889080, LOC122889081, LOC122889082, LOC122889083, LOC122889084, LOC122889085, LOC122889086, LOC122889087, LOC122889088, LOC126806671, LOC126806672, LOC126806673, LOC126806674, LOC126806675, LOC126806676, LOC127898564, LOC129389065, LOC129389066, LOC129389067, LOC129389068, LOC129389069, LOC129389070, LOC129389071, LOC129389072, LOC129389073, LOC129389074, LOC129389075, LOC129389076, LOC129389077, LOC129936634, LOC129936635, LOC129936636, LOC129936637, LOC129936638, LOC129936639, LOC129936640, LOC129936641, LOC129936642, LOC129936643, LOC129936644, LOC129936645, LOC129936646, LOC129936647, LOC129936648, LOC129936649, LOC129936650, LOC129936651, LOC129936652, LOC129936653, LOC129936654, LOC129936655, LOC129936656, LOC129936657, LOC129936658, LOC129936659, LOC129936660, LOC129936661, LOC129936662, LOC129936663, LOC129936664, LOC129936665, LOC129936666, LOC129936667, LOC129936668, LOC129936669, LOC129936670, LOC129936671, LOC129936672, LOC129936673, LOC129936674, LOC129936675, LOC129936676, LOC129936677, LOC129936678, LOC129936679, LOC129936680, LOC129936681, LOC129936682, LOC129936683, LOC129936684, LOC129936685, LOC129936686, LOC129936687, LOC129936688, LOC129936689, LOC129936690, LOC129936691, LOC129936692, LOC129936693, LOC129936694, LOC129936695, LOC129936696, LOC129936697, LOC129936698, LOC129936699, LOC129936700, LOC129936701, LOC129936702, LOC129936703, LOC129936704, LOC129936705, LOC129936706, LOC129936707, LOC129936708, LOC129936709, LOC129936710, LOC129936711, LOC129936712, LOC129936713, LOC129936714, LOC129936715, LOC129936716, LOC129936717, LOC129936718, LOC129936719, LOC129936720, LOC129936721, LOC129936722, LOC129936723, LOC129936724, LOC129936725, LOC129936726, LOC129936727, LOC129936728, LOC129936729, LOC129936730, LOC129936731, LOC129936732, LOC129936733, LOC129936734, LOC129936735, LOC129936736, LOC129936737, LOC129936738, LOC129936739, LOC129936740, LOC129936741, LOC129936742, LOC129936743, LOC129936744, LOC129936745, LOC129936746, LOC129936747, LOC129936748, LOC129936749, LOC129936750, LOC129936751, LOC129936752, LOC129936753, LOC129936754, LOC129936755, LOC129936756, LOC129936757, LOC129936758, LOC129936759, LOC129936760, LOC129936761, LOC129936762, LOC129936763, LOC129936764, LOC129936765, LOC129936766, LOC129936767, LOC129936768, LOC129936769, LOC129936770, LOC129936771, LOC129936772, LOC129936773, LOC129936774, LOC129936775, LOC129936776, LOC129936777, LOC129936778, LOC129936779, LOC129936780, LOC129936781, LOC129936782, LOC129936783, LOC129936784, LOC129936785, LOC129936786, LOC129936787, LOC129936788, LOC129936789, LOC129936790, LOC129936791, LOC129936792, LOC129936793, LOC129936794, LOC129936795, LOC129936796, LOC129936797, LOC129936798, LOC129936799, LOC129936800, LOC129936801, LOC129936802, LOC129936803, LOC129936804, LOC129936805, LOC129936806, LOC129936807, LOC129936808, LOC129936809, LOC129936810, LOC129936811, LOC132088966, LOC132088967, LOC132088968, LOC132088969, LOC132088970, LRRC2, LRRC2-AS1, LSMEM2, LTF, LZTFL1, MAP4, MAPKAPK3, MIR1226, MIR191, MIR2115, MIR425, MIR4271, MIR4443, MIR4787, MIR4793, MIR5193, MIR5787, MIR6823, MIR6824, MIR6872, MIR6890, MIR711, MON1A, MST1, MST1R, MYL3, NAA80, NBEAL2, NCKIPSD, NDUFAF3, NICN1, NME6, NPRL2, P4HTM, PFKFB4, PLXNB1, PRKAR2A, PRKAR2A-AS1, PRSS50, PTH1R, PTPN23, PTPN23-DT, QARS1, QRICH1, RASSF1, RASSF1-AS1, RBM5, RBM5-AS1, RBM6, RHOA, RNF123, RTP3, SCAP, SEMA3B, SEMA3B-AS1, SEMA3F, SEMA3F-AS1, SETD2, SHISA5, SLC25A20, SLC26A6, SLC38A3, SMARCC1, SNORA94, SNORD13J, SNORD146, SPINK8, TCTA, TMA7, TMEM115, TMEM89, TMIE, TRAIP, TREX1, TUSC2, UBA7, UCN2, UQCRC1, USP19, USP4, WDR6, XCR1, ZMYND10, ZNF589
See casesPathogenic
(Sep 23, 2013)
no assertion criteria provided
2.
GRCh37:
Chr3:48600388-48624921
GRCh38:
Chr3:48562955-48587488
UCN2, PFKFB4, COL7A1, MIR711Ductal breast carcinomaUncertain significance
(Jul 20, 2015)
no assertion criteria provided
3.
GRCh37:
Chr3:48601569
GRCh38:
Chr3:48564136
COL7A1Epidermolysis bullosa dystrophicaUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
4.
GRCh37:
Chr3:48601623
GRCh38:
Chr3:48564190
COL7A1Epidermolysis bullosa dystrophicaBenign
(Jan 12, 2018)
criteria provided, single submitter
5.
GRCh37:
Chr3:48601677
GRCh38:
Chr3:48564244
COL7A1Epidermolysis bullosa dystrophicaUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
6.
GRCh37:
Chr3:48601677
GRCh38:
Chr3:48564244
COL7A1Epidermolysis bullosa dystrophicaLikely benign
(Jan 13, 2018)
criteria provided, single submitter
7.
GRCh37:
Chr3:48601734
GRCh38:
Chr3:48564301
COL7A1Epidermolysis bullosa dystrophicaUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
8.
GRCh37:
Chr3:48601752
GRCh38:
Chr3:48564319
COL7A1Epidermolysis bullosa dystrophicaUncertain significance
(Apr 27, 2017)
criteria provided, single submitter
9.
GRCh37:
Chr3:48601774
GRCh38:
Chr3:48564341
COL7A1Epidermolysis bullosa dystrophicaBenign
(Jan 13, 2018)
criteria provided, single submitter
10.
GRCh37:
Chr3:48601799
GRCh38:
Chr3:48564366
COL7A1Epidermolysis bullosa dystrophicaUncertain significance
(Jan 13, 2018)
criteria provided, single submitter
11.
GRCh37:
Chr3:48601850
GRCh38:
Chr3:48564417
COL7A1A2942Snot providedUncertain significance
(Oct 28, 2021)
criteria provided, single submitter
12.
GRCh37:
Chr3:48601858
GRCh38:
Chr3:48564425
COL7A1not providedLikely benign
(Oct 23, 2022)
criteria provided, single submitter
13.
GRCh37:
Chr3:48601861
GRCh38:
Chr3:48564428
COL7A1not providedLikely benign
(Jun 15, 2022)
criteria provided, single submitter
14.
GRCh37:
Chr3:48601873
GRCh38:
Chr3:48564440
COL7A1not providedLikely benign
(Jan 16, 2022)
criteria provided, single submitter
15.
GRCh37:
Chr3:48602196
GRCh38:
Chr3:48564763
COL7A1not providedLikely benign
(May 8, 2022)
criteria provided, single submitter
16.
GRCh37:
Chr3:48602206
GRCh38:
Chr3:48564773
COL7A1not providedLikely benign
(Mar 8, 2022)
criteria provided, single submitter
17.
GRCh37:
Chr3:48602207
GRCh38:
Chr3:48564774
COL7A1not providedLikely benign
(Feb 20, 2022)
criteria provided, single submitter
18.
GRCh37:
Chr3:48602212
GRCh38:
Chr3:48564779
COL7A1not providedUncertain significance
(Aug 24, 2022)
criteria provided, single submitter
19.
GRCh37:
Chr3:48602214
GRCh38:
Chr3:48564781
COL7A1not providedUncertain significance
(Jul 14, 2021)
criteria provided, single submitter
20.
GRCh37:
Chr3:48602217
GRCh38:
Chr3:48564784
COL7A1Epidermolysis bullosa dystrophica inversa, autosomal recessiveUncertain significance
(Nov 14, 2020)
no assertion criteria provided
21.
GRCh37:
Chr3:48602220
GRCh38:
Chr3:48564787
COL7A1not providedLikely benign
(Aug 12, 2021)
criteria provided, single submitter
22.
GRCh37:
Chr3:48602225
GRCh38:
Chr3:48564792
COL7A1Q2937Enot providedUncertain significance
(Aug 29, 2022)
criteria provided, single submitter
23.
GRCh37:
Chr3:48602226
GRCh38:
Chr3:48564793
COL7A1S2936Rnot providedBenign
(Sep 10, 2022)
criteria provided, single submitter
24.
GRCh37:
Chr3:48602231
GRCh38:
Chr3:48564798
COL7A1Q2935*not provided, Epidermolysis bullosa pruriginosaConflicting interpretations of pathogenicity
(Aug 28, 2022)
criteria provided, conflicting interpretations
25.
GRCh37:
Chr3:48602234
GRCh38:
Chr3:48564801
COL7A1V2934Fnot specifiedUncertain significance
(Aug 9, 2023)
criteria provided, single submitter
26.
GRCh37:
Chr3:48602237
GRCh38:
Chr3:48564804
COL7A1V2933Lnot providedUncertain significance
(May 22, 2022)
criteria provided, single submitter
27.
GRCh37:
Chr3:48602238
GRCh38:
Chr3:48564805
COL7A1not providedLikely benign
(Jul 20, 2022)
criteria provided, single submitter
28.
GRCh37:
Chr3:48602240
GRCh38:
Chr3:48564807
COL7A1R2932Wnot providedLikely benign
(Aug 19, 2022)
criteria provided, single submitter
29.
GRCh37:
Chr3:48602241
GRCh38:
Chr3:48564808
COL7A1not providedLikely benign
(Sep 14, 2022)
criteria provided, single submitter
30.
GRCh37:
Chr3:48602243
GRCh38:
Chr3:48564810
COL7A1P2931Snot providedLikely benign
(Oct 11, 2022)
criteria provided, single submitter
31.
GRCh37:
Chr3:48602244
GRCh38:
Chr3:48564811
COL7A1not providedLikely benign
(Apr 24, 2022)
criteria provided, single submitter
32.
GRCh37:
Chr3:48602251
GRCh38:
Chr3:48564818
COL7A1R2928Hnot provided, Epidermolysis bullosa dystrophicaConflicting interpretations of pathogenicity
(May 10, 2023)
criteria provided, conflicting interpretations
33.
GRCh37:
Chr3:48602252
GRCh38:
Chr3:48564819
COL7A1R2928Cnot providedUncertain significance
(Mar 29, 2022)
criteria provided, single submitter
34.
GRCh37:
Chr3:48602254
GRCh38:
Chr3:48564821
COL7A1R2927HNonsyndromic congenital nail disorder 8, Pretibial blistering, Epidermolysis bullosa pruriginosa,
Dominant dystrophic epidermolysis bullosa with absence of skin, Recessive dystrophic epidermolysis bullosa, Generalized dominant dystrophic epidermolysis bullosa,
Transient bullous dermolysis of the newborn, not provided
Conflicting interpretations of pathogenicity
(Oct 26, 2022)
criteria provided, conflicting interpretations
35.
GRCh37:
Chr3:48602255
GRCh38:
Chr3:48564822
COL7A1R2927Cnot provided, Epidermolysis bullosa dystrophicaConflicting interpretations of pathogenicity
(Jun 23, 2022)
criteria provided, conflicting interpretations
36.
GRCh37:
Chr3:48602264
GRCh38:
Chr3:48564831
COL7A1A2924Tnot providedUncertain significance
(Aug 1, 2023)
criteria provided, single submitter
37.
GRCh37:
Chr3:48602265
GRCh38:
Chr3:48564832
COL7A1not providedLikely benign
(Apr 14, 2022)
criteria provided, single submitter
38.
GRCh37:
Chr3:48602271
GRCh38:
Chr3:48564838
COL7A1not providedLikely benign
(Feb 16, 2021)
criteria provided, single submitter
39.
GRCh37:
Chr3:48602273
GRCh38:
Chr3:48564840
COL7A1T2921Anot providedUncertain significance
(May 7, 2021)
criteria provided, single submitter
40.
GRCh37:
Chr3:48602274
GRCh38:
Chr3:48564841
COL7A1not providedLikely benign
(Jul 23, 2020)
criteria provided, single submitter
41.
GRCh37:
Chr3:48602275
GRCh38:
Chr3:48564842
COL7A1G2920Enot providedUncertain significance
(Jul 7, 2021)
criteria provided, single submitter
42.
GRCh37:
Chr3:48602282
GRCh38:
Chr3:48564849
COL7A1R2918Cnot providedUncertain significance
(Apr 1, 2022)
criteria provided, single submitter
43.
GRCh37:
Chr3:48602286
GRCh38:
Chr3:48564853
COL7A1not providedLikely benign
(Aug 24, 2022)
criteria provided, single submitter
44.
GRCh37:
Chr3:48602287
GRCh38:
Chr3:48564854
COL7A1A2916Vnot providedUncertain significance
(Nov 23, 2020)
criteria provided, single submitter
45.
GRCh37:
Chr3:48602308
GRCh38:
Chr3:48564875
COL7A1Y2909Cnot providedUncertain significance
(Jul 6, 2022)
criteria provided, single submitter
46.
GRCh37:
Chr3:48602317
GRCh38:
Chr3:48564884
COL7A1P2906fsEpidermolysis bullosa dystrophicaPathogenic
(Nov 26, 2018)
criteria provided, single submitter
47.
GRCh37:
Chr3:48602318
GRCh38:
Chr3:48564885
COL7A1P2906Anot providedUncertain significance
(Mar 12, 2022)
criteria provided, single submitter
48.
GRCh37:
Chr3:48602325
GRCh38:
Chr3:48564892
COL7A1not providedLikely benign
(Jul 11, 2022)
criteria provided, single submitter
49.
GRCh37:
Chr3:48602325
GRCh38:
Chr3:48564892
COL7A1not providedLikely benign
(Feb 19, 2022)
criteria provided, single submitter
50.
GRCh37:
Chr3:48602326-48602336
GRCh38:
Chr3:48564893-48564903
COL7A1S2900fsnot providedPathogenic
(Sep 3, 2022)
criteria provided, single submitter
51.
GRCh37:
Chr3:48602327
GRCh38:
Chr3:48564894
COL7A1A2903Tnot providedLikely benign
(Nov 1, 2022)
criteria provided, single submitter
52.
GRCh37:
Chr3:48602327
GRCh38:
Chr3:48564894
COL7A1A2903fsnot providedPathogenic
(Mar 17, 2022)
criteria provided, single submitter
53.
GRCh37:
Chr3:48602349
GRCh38:
Chr3:48564916
COL7A1not providedLikely benign
(Jul 3, 2022)
criteria provided, single submitter
54.
GRCh37:
Chr3:48602349
GRCh38:
Chr3:48564916
COL7A1not providedLikely benign
(Feb 9, 2022)
criteria provided, single submitter
55.
GRCh37:
Chr3:48602350
GRCh38:
Chr3:48564917
COL7A1R2895Pnot providedUncertain significance
(Nov 13, 2021)
criteria provided, single submitter
56.
GRCh37:
Chr3:48602350
GRCh38:
Chr3:48564917
COL7A1R2895Qnot providedUncertain significance
(Feb 2, 2022)
criteria provided, single submitter
57.
GRCh37:
Chr3:48602355
GRCh38:
Chr3:48564922
COL7A1Y2893*not providedPathogenic
(Aug 24, 2019)
criteria provided, single submitter
58.
GRCh37:
Chr3:48602358
GRCh38:
Chr3:48564925
COL7A1W2892Cnot providedUncertain significance
(May 12, 2022)
criteria provided, single submitter
59.
GRCh37:
Chr3:48602361
GRCh38:
Chr3:48564928
COL7A1not providedLikely benign
(Sep 29, 2022)
criteria provided, single submitter
60.
GRCh37:
Chr3:48602363
GRCh38:
Chr3:48564930
COL7A1R2891Cnot providedUncertain significance
(Feb 25, 2022)
criteria provided, single submitter
61.
GRCh37:
Chr3:48602366
GRCh38:
Chr3:48564933
COL7A1not providedLikely benign
(Sep 14, 2022)
criteria provided, single submitter
62.
GRCh37:
Chr3:48602367
GRCh38:
Chr3:48564934
COL7A1not providedLikely benign
(Oct 17, 2022)
criteria provided, single submitter
63.
GRCh37:
Chr3:48602367
GRCh38:
Chr3:48564934
COL7A1not providedLikely benign
(Sep 22, 2021)
criteria provided, single submitter
64.
GRCh37:
Chr3:48602368
GRCh38:
Chr3:48564935
COL7A1T2889Inot providedUncertain significance
(Feb 6, 2022)
criteria provided, single submitter
65.
GRCh37:
Chr3:48602370
GRCh38:
Chr3:48564937
COL7A1not providedPathogenic
(Sep 3, 2022)
criteria provided, single submitter
66.
GRCh37:
Chr3:48602370
GRCh38:
Chr3:48564937
COL7A1not providedLikely benign
(Aug 21, 2022)
criteria provided, single submitter
67.
GRCh37:
Chr3:48602373
GRCh38:
Chr3:48564940
COL7A1not providedLikely benign
(Sep 25, 2022)
criteria provided, single submitter
68.
GRCh37:
Chr3:48602377
GRCh38:
Chr3:48564944
COL7A1T2886Inot providedUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
69.
GRCh37:
Chr3:48602380
GRCh38:
Chr3:48564947
COL7A1C2885Ynot providedPathogenic
(Aug 1, 2022)
criteria provided, single submitter
70.
GRCh37:
Chr3:48602387
GRCh38:
Chr3:48564954
COL7A1G2883Snot providedUncertain significance
(May 31, 2021)
criteria provided, single submitter
71.
GRCh37:
Chr3:48602399
GRCh38:
Chr3:48564966
COL7A1P2879Snot providedUncertain significance
(Jul 13, 2022)
criteria provided, single submitter
72.
GRCh37:
Chr3:48602403
GRCh38:
Chr3:48564970
COL7A1Epidermolysis bullosa dystrophicaUncertain significance
(Jan 12, 2018)
criteria provided, single submitter
73.
GRCh37:
Chr3:48602408
GRCh38:
Chr3:48564975
COL7A1C2876Rnot providedLikely pathogenic
(Sep 13, 2022)
criteria provided, single submitter
74.
GRCh37:
Chr3:48602418
GRCh38:
Chr3:48564985
COL7A1not providedLikely benign
(Nov 30, 2021)
criteria provided, single submitter
75.
GRCh37:
Chr3:48602418
GRCh38:
Chr3:48564985
COL7A1not providedLikely benign
(Aug 7, 2021)
criteria provided, single submitter
76.
GRCh37:
Chr3:48602422
GRCh38:
Chr3:48564989
COL7A1not providedLikely benign
(Jun 18, 2021)
criteria provided, single submitter
77.
GRCh37:
Chr3:48602516
GRCh38:
Chr3:48565083
COL7A1not providedLikely benign
(Jun 3, 2022)
criteria provided, single submitter
78.
GRCh37:
Chr3:48602519
GRCh38:
Chr3:48565086
COL7A1not providedBenign
(Mar 8, 2019)
criteria provided, single submitter
79.
GRCh37:
Chr3:48602523-48602524
GRCh38:
Chr3:48565090-48565091
COL7A1not providedLikely benign
(Aug 16, 2022)
criteria provided, single submitter
80.
GRCh37:
Chr3:48602523-48602524
GRCh38:
Chr3:48565090-48565091
COL7A1not provided, not specifiedBenign/Likely benign
(Nov 4, 2022)
criteria provided, multiple submitters, no conflicts
81.
GRCh37:
Chr3:48602524-48602525
GRCh38:
Chr3:48565091-48565092
COL7A1not providedBenign
(Jun 13, 2022)
criteria provided, single submitter
82.
GRCh37:
Chr3:48602532
GRCh38:
Chr3:48565099
COL7A1not providedLikely benign
(Jun 6, 2021)
criteria provided, single submitter
83.
GRCh37:
Chr3:48602534
GRCh38:
Chr3:48565101
COL7A1not providedLikely benign
(Sep 19, 2021)
criteria provided, single submitter
84.
GRCh37:
Chr3:48602550
GRCh38:
Chr3:48565117
COL7A1D2871Gnot providedUncertain significance
(Oct 2, 2020)
criteria provided, single submitter
85.
GRCh37:
Chr3:48602551
GRCh38:
Chr3:48565118
COL7A1D2871Nnot provided, Epidermolysis bullosa dystrophicaConflicting interpretations of pathogenicity
(Sep 20, 2022)
criteria provided, conflicting interpretations
86.
GRCh37:
Chr3:48602552
GRCh38:
Chr3:48565119
COL7A1W2870Cnot providedUncertain significance
(Sep 2, 2022)
criteria provided, single submitter
87.
GRCh37:
Chr3:48602561
GRCh38:
Chr3:48565128
COL7A1not providedLikely benign
(Mar 18, 2022)
criteria provided, single submitter
88.
GRCh37:
Chr3:48602573
GRCh38:
Chr3:48565140
COL7A1not providedLikely benign
(Sep 30, 2020)
criteria provided, single submitter
89.
GRCh37:
Chr3:48602576
GRCh38:
Chr3:48565143
COL7A1not providedLikely benign
(Nov 16, 2021)
criteria provided, single submitter
90.
GRCh37:
Chr3:48602578
GRCh38:
Chr3:48565145
COL7A1E2862*not providedPathogenic
(Oct 27, 2020)
criteria provided, single submitter
91.
GRCh37:
Chr3:48602579
GRCh38:
Chr3:48565146
COL7A1not providedLikely benign
(Dec 15, 2021)
criteria provided, single submitter
92.
GRCh37:
Chr3:48602581
GRCh38:
Chr3:48565148
COL7A1E2861Qnot providedUncertain significance
(Jun 23, 2022)
criteria provided, single submitter
93.
GRCh37:
Chr3:48602588
GRCh38:
Chr3:48565155
COL7A1Y2858*not providedPathogenic
(Sep 1, 2022)
criteria provided, single submitter
94.
GRCh37:
Chr3:48602590
GRCh38:
Chr3:48565157
COL7A1Y2858HEpidermolysis bullosa dystrophicaPathogenic
(Nov 26, 2018)
criteria provided, single submitter
95.
GRCh37:
Chr3:48602593
GRCh38:
Chr3:48565160
COL7A1E2857*Recessive dystrophic epidermolysis bullosaLikely pathogeniccriteria provided, single submitter
96.
GRCh37:
Chr3:48602593
GRCh38:
Chr3:48565160
COL7A1E2857KInborn genetic diseases, not providedConflicting interpretations of pathogenicity
(Jan 11, 2023)
criteria provided, conflicting interpretations
97.
GRCh37:
Chr3:48602594-48602604
GRCh38:
Chr3:48565161-48565171
COL7A1not providedPathogenic
(May 20, 2019)
criteria provided, single submitter
98.
GRCh37:
Chr3:48602594
GRCh38:
Chr3:48565161
COL7A1not provided, Epidermolysis bullosa dystrophicaConflicting interpretations of pathogenicity
(Oct 27, 2022)
criteria provided, conflicting interpretations
99.
GRCh37:
Chr3:48602597-48602625
GRCh38:
Chr3:48565164-48565192
COL7A1P2846fsEpidermolysis bullosa dystrophicaPathogenic
(Feb 26, 2018)
criteria provided, single submitter
100.
GRCh37:
Chr3:48602620
GRCh38:
Chr3:48565187
COL7A1E2848Knot providedUncertain significance
(Aug 27, 2021)
criteria provided, single submitter
Format
Items per page
Sort by
Choose Destination